Assessment of risk factors for preterm birth

Obstetrics and Gynecology

Volumn 98, Issue 4, 2001, Pages 709-716

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FIBRONECTIN; ESTRIOL; FFN PROTEIN, HUMAN; GLYCOPROTEIN;

CLINICAL PRACTICE; GESTATIONAL AGE; HUMAN; INCIDENCE; MULTIPLE PREGNANCY; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREDICTION; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TRANSVAGINAL ECHOGRAPHY; UNITED STATES; UTERUS CONTRACTION; VAGINITIS; ARTICLE; CHEMISTRY; ECHOGRAPHY; FEMALE; FETUS MONITORING; NEWBORN; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; PREGNANCY; SALIVA; UTERINE CERVIX;

CERVIX UTERI; ESTRIOL; FEMALE; FIBRONECTINS; GLYCOPROTEINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE OF TESTS; PREGNANCY; RISK FACTORS; SALIVA; UTERINE MONITORING; VAGINOSIS, BACTERIAL;

EID: 0034813181     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-200110000-00035     Document Type: Review

References (80)

1. Deaths: Final data for 1998
2. Etiologies of preterm birth in an indigent population: Is prevention a logical expectation?
3. Neurologic and developmental disability after extremely preterm birth
4. Preterm singleton births - United States, 1989-1996
5. Preterm birth
6. Births: Final data for 1999
7. The preterm prediction study: The value of new vs. standard risk factors in predicting early and all spontaneous preterm births
8. The control of labor
9. Stress-associated preterm delivery: The role of corticotropin-releasing hormone
10. Intrauterine infection and preterm delivery
11. Effect of corticosteroids for fetal maturation on perinatal outcomes
12. Antenatal corticosteroids revisited: Repeat courses
13. Any tocolytic drug for preterm labour (Protocol for a Cochrane Review)
14. The epidemiology of preterm birth
15. Intrauterine growth retardation and preterm delivery: Perinatal risk factors in an indigent population
16. Unfavorable outcome in penultimate pregnancy and premature rupture of membranes in successive pregnancy
17. Gestational vaginal bleeding and pregnancy outcome
18. The association between occupational factors and preterm birth: A United States nurses' study
19. The influence of gestational age and smoking habits on the risk of subsequent preterm deliveries
20. Effects of maternal smoking on adverse pregnancy outcomes: Examination of the criteria of causation
21. System for predicting spontaneous preterm birth
22. Can preterm deliveries be prevented?
23. The preterm prediction study: A clinical risk assessment system
24. Quantitation of uterine activity preceding preterm, term and postterm labor
25. A role for estriol in human labor, term and preterm
26. Diurnal variation in salivary estriol level during pregnancy: A pilot study
27. Serial betamethasone administration: Effect on maternal salivary estriol levels
28. Bacterial vaginosis in women attending STD clinic: Diagnostic criteria and prevalence of mobiluncus spp.
29. History and review of bacterial vaginosis
30. Race/ethnicity, vaginal flora patterns, and pH during pregnancy
31. The preterm prediction study: Significance of vaginal infections
32. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant
33. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery
34. Is oncofetal fibronectin a trophoblast glue for human implantation?
35. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population
36. The preterm prediction study: Fetal fibronectin, bacterial vaginosis, and peripartum infection
37. Measurement of cervical length in pregnancy: Comparison between vaginal ultrasonography and digital examination
38. The length of the cervix and the risk of spontaneous premature delivery
39. A randomized comparison of home uterine activity monitoring in the outpatient management of women treated for preterm labor
40. Prevention of preterm birth in high-risk patients: The role of education and provider contact versus home uterine monitoring
41. Monitoring women at risk for preterm labor
42. A prospective random trial of home uterine monitoring in pregnancies at increased risk of preterm labor. Part II
43. A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor
44. Home uterine activity monitoring in France: A randomized controlled trial
45. Home uterine activity monitoring is associated with a reduction in preterm birth
46. Preventing preterm birth in twin gestation: Home uterine activity monitoring and perinatal nursing support
47. Prevention of preterm birth by ambulatory assessment of uterine activity: A randomized study
48. Multicenter randomized clinical trial of home uterine activity monitoring for the detection of preterm labor
49. Randomized comparison of home uterine activity monitoring and routine care in patients discharged after treatment for preterm labor
50. A randomized multicenter trial assessing a home uterine activity monitoring device used in the absence of daily nursing contact
51. Management of preterm labor patients at home: Does daily uterine activity monitoring and nursing support make a difference?
52. Randomized controlled trials of home uterine activity monitoring: A review and critique
53. Home monitoring of uterine activity. Does it prevent prematurity?
54. Reanalysis of a multireported trial on home uterine activity monitoring
55. Home uterine activity monitoring for preterm labor. Review article
56. A multicenter randomized controlled trial of home uterine monitoring: Active versus sham device
57. A metaanalysis of home uterine activity monitoring
58. Salivary estriol as risk assessment for preterm labor: A prospective trial
59. Accuracy of salivary estriol testing compared to traditional risk factor assessment in predicting preterm birth
60. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled, double-blind study
61. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis
62. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy
63. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis
64. Interventions for treating bacterial vaginosis in pregnancy (Cochrane Review)
65. Screening for bacterial vaginosis in pregnancy. Recommendations and rationale
66. The preterm prediction study: Cervical lactoferin concentration, other markers of lower genital tract infection, and preterm birth
67. Cervicovaginal fetal fibronectin as a marker for preterm delivery: A meta-analysis
68. The Preterm Prediction Study: Sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth
69. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: Relation to outcome
70. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth
71. Fetal fibronectin as a predictor of preterm birth: An overview
72. Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimetics
73. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial
74. Transvaginal ultrasound in the prediction of preterm delivery: Singleton and twin gestations
75. Cervical ultrasonography compared with manual examination as a predictor of preterm delivery
76. Observations on the sonographic measurement of cervical length and the risk of preterm birth
77. Cervical length and dilatation of the internal cervical os detected by vaginal ultrasonography as markers for preterm delivery: A systematic review
78. Ultrasound cervical assessment in predicting preterm birth. SOGC Clinical Practice Guidelines 102
79. The Preterm Prediction Study: Recurrence risk of spontaneous preterm birth